Study participant demographic characteristics
| Characteristic | Foreign-born, HIV-seronegative, aged ≥5 years (n=7931) | Foreign-born, HIV-seronegative, aged <5 years (n=464) | Foreign-born, HIV-seropositive, aged ≥5 years (n=140) | US-born, HIV-seronegative, aged ≥5 years (n=775) | US-born, HIV-seropositive, aged ≥5 years (n=1226) |
| Age, years (median, IQR) | 28.9 (18.9–40.6) | 3.1 (2.2–4.0) | 46.4 (37.6–56.0) | 36.6 (22.3–51.0) | 49.6 (42.6–54.8) |
| TB incidence/100 000 population in country of birth | n (%) | n (%) | n (%) | n (%) | n (%) |
| 0 – 9.9 | 30 (0.4) | 5 (1.1) | 23 (16.4%) | 775 (100%) | 1226 (100%) |
| 10 – 19 | 69 (0.9) | 19 (4.1) | 5 (3.6%) | 0 | 0 |
| 20 – 49 | 1445 (18.2) | 60 (12.9) | 39 (27.9%) | 0 | 0 |
| 50 – 124 | 1072 (13.5) | 213 (45.9) | 16 (11.4%) | 0 | 0 |
| 125 – 299 | 3374 (42.5) | 139 (30.0) | 36 (25.7%) | 0 | 0 |
| 300 – 499 | 1893 (23.9) | 15 (3.2) | 20 (14.3%) | 0 | 0 |
| ≥ 500 | 48 (0.6) | 13 (2.8) | 1 (0.7%) | 0 | 0 |
| CD4+ T-lymphocyte count (median, IQR) | NA | NA | 555 (255–713)* | NA | 544 (355–761)† |
*76 foreign-born, HIV-seropositive participants aged ≥5 years had available self-reported CD4+ lymphocyte count data.
†789 US-born, HIV-seropositive participants aged ≥5 years had available self-reported CD4+ lymphocyte count data.
NA, not applicable.